Human TGF-β1 (Transforming Growth Factor Beta 1) ELISA Kit

SKU:BHE10803263
Overview
Click light‑blue chips for details
Quantitative double-antibody sandwich ELISA kit for measuring human TGF-β1 (Transforming Growth Factor Beta 1) in Serum, Plasma, Cell Culture Supernatant, and cell or tissue lysate. Includes sensitivity 18.75pg/mL, detection range 31.25–2000pg/mL for immunology research. Includes assay time 4 hours.
Target TGF-β1
Species Human
Sample Type(s) Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples
Assay Type Sandwich ELISA, Double Antibody
Sensitivity 18.75pg/ml
Detection Range 31.25-2000pg/ml
Assay Time 4 hours
Options selector
Catalog no. Size
EH0287-96T 96 T
Available Options

Select the variant options shown for this product and review lead time and shipping expectations before ordering.

  • Size: 96 tests (96T) kit.
  • Lead time: options listed as “in stock at manufacturer” typically ship in 5–7 business days.
  • Storage: 2-8 °C for 12 months; ships cold (typically with ice packs) is expected.
  • Please ensure someone is available to receive and store the shipment promptly.
  • Sales terms and conditions: Please review prior to ordering.
Field Specification
Mfr No EH0287
Alternative Names Transforming growth factor beta-1 proprotein|Latency-associated peptide|LAP|Transforming growth factor beta-1|TGF-beta-1|TGFB1|TGFB
Assay Time
  • 4 hours
Detection Method
  • Sandwich ELISA
  • Double Antibody
Detection Range 31.25-2000pg/ml
Product Type
  • ELISA Kits
Reactivity
  • Human
Sample Type(s) Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples
Sensitivity 18.75pg/ml
Species Human
Storage 2-8 °C for 12 months
Target TGF-β1
UniProt # P01137

Background

human TGF-β1 (Transforming Growth Factor Beta 1) is a molecular target commonly studied in immunology, cardiovascular, and cancer research. Growth factors are signaling proteins that influence proliferation, differentiation, and tissue remodeling through receptor activation.

Biological role and mechanism

The biological role of TGF-β1 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.

Expression and abundance of TGF-β1 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.

Nomenclature and related terms

TGF-β1 (Transforming Growth Factor Beta 1) may also be referenced as Transforming growth factor beta-1 proprotein, Latency-associated peptide, and LAP in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).

Why it matters in research

  • Understanding how TGF-β1 relates to innate and adaptive immune responses, cytokine signaling networks, host–pathogen interactions, and immune cell activation and trafficking in immunology, cardiovascular, and cancer research.
  • Interpreting shifts in TGF-β1 levels alongside other pathway components or complementary markers.
  • Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).

Molecular forms and interpretation

For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.

Disease and translational relevance

TGF-β1 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with immunology, cardiovascular, and cancer studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.

?What?s the plate size in FineTest? ELISA Kits?
The ELISA plate follows the standard size of microplate: 127.64 mm x 85.60 mm x 14.22 mm(L x W x H).
?How about the shelf life and stability of FineTest? ELISA Kits?
Valid for 12 months since the production date. For the shelf life of specific batch number, please check the label printed on the kit. Before delivery, all FineTest? ELISA Kits have been subject to strict quality test.
?Which cloned antibodies for FineTest? ELISA Kits are used?
These information is proprietary. Please contact us to learn more about clonality (polyclonality or monoclonality) and host species.
?Can I mix reagents from different batches of FineTest? ELISA Kits?
Not suggested. ELISA reagents are optimized for specific batch.
?Can FineTest? ELISA Kits be used partially?
Yes. The ELISA plate is dismounted. Enough component volumes are offered by 96T ELISA kit, supporting two groups of standard curve.
?How long can the diluted lyophilized standard be stored for continual use?
Used up within 12h.
?Can standard curve be extended to any direction?
FineTest? can't support validation of standard concentration outside of standard curve. Ranges of standard curve have been validated among many batches and experimenters, showing stable and accurate performance. The lowest standard concentration is the minimized range for reliable detection results. Adding higher or lower concentration of standard may cause inconsistent signal or false positive.
?Why does detection for serum/plasma sample by FineTest? ELISA Kits require for 1/2 dilution?
Matrix components in serum/plasma can affect detection results. Blocking components in sample dilution buffer can decrease or remove the interference. The dilution can reduce the matrix difference between sample and standard to get better accuracy.
?What?s the half-life of protein in serum/plasma/cell culture supernatant?
FineTest? can't determine the half-life of protein in the sample(e.g. serum, plasma or cell culture supernatant). Usually, it's suggested to detect prepared sample immediately or aliquot sample to refrigerate in a disposable container. Avoid freeze-thaw cycle to prevent protein degradation.
?What's the expected concentration for particularly analyzing my sample?
Due to the specificity of each sample, it's hard to forecast and depend on sample preparation as well as analytical characteristics. Please contact us to get detection data for reference.

Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.

Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p/STAT6 axis to promote gastric cancer progression

IF: 37.3 Journal: Molecular Cancer Author: Digestive Diseases Center, Guangdong Provincial Key Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China. Cited Date: 2024-03-15

Exploring association of melanoma-specific Bcl-xL with tumor immune microenvironment

IF: 11.3 Journal: Journal of Experimental & Clinical Cancer Research Author: Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy Cited Date: 2023-07-28

Ceria‐Nanoparticle‐Entangled Reticulation for Angiogenic and Therapeutic Embrocation for Multifactorial Approach to Treat Diabetic Wound

IF: 10 Journal: Advanced Healthcare Materials Author: Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul, 08826, Republic of Korea. Cited Date: 2025-04-11

Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance

IF: 8.756 Journal: Oncogene Cited Date: 2022-12-02

Glyphosate targets FYN to regulate glycolysis and promote glioblastoma proliferation: A network toxicology study

IF: 8.5 Journal: International Journal of Biological Macromolecules Author: Department of Prosthodontics, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University & Shandong Key Laboratory of Oral Tissue Regeneration & Shandong Engineering Research Center of Dental Materials and Oral Tissue Regeneratio Cited Date: 2025-10-11

Candidate Biomarkers for the Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes

IF: 7.561 Journal: Frontiers in Immunology Cited Date: 2022-03-18

DcR3 suppresses the NF-κB pathway and the NLRP3 inflammasome activation in gouty inflammation

IF: 7.5 Journal: Chinese Medical Journal Author: Research Center of Hyperuricemia and Gout, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, China. Cited Date: 2024-09-27

DOP03 The correlation of regulatory miRNAs with cytokine serum levels and cytokine genes’ polymorphisms

IF: 6.992 Journal: Journal of Crohn's and Colitis Cited Date: 2019-01-25

A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study

IF: 6.63 Journal: Cancer Immunology, Immunotherapy Cited Date: 2022-09-15

Can FineTest® ELISA Kits be used partially?
Yes. The ELISA plate is dismounted. Enough component volumes are offered by 96T ELISA kit, supporting two groups of standard curve.
What’s the half-life of protein in serum/plasma/cell culture supernatant?
FineTest® can't determine the half-life of protein in the sample(e.g. serum, plasma or cell culture supernatant). Usually, it's suggested to detect prepared sample immediately or aliquot sample to refrigerate in a disposable container. Avoid freeze-thaw cycle to prevent protein degradation.

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today